Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
2.200
+0.050 (2.33%)
At close: Jul 8, 2025, 4:00 PM
2.240
+0.040 (1.82%)
After-hours: Jul 8, 2025, 7:52 PM EDT
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of $335.64 million as of July 8, 2025. Its market cap has decreased by -34.85% in one year.
Market Cap
335.64M
Enterprise Value
462.22M
1-Year Change
-34.85%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $335.64M, an increase of 163.45%. That is a compound annual growth rate of 3.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 7, 2025 | 328.00M | 40.95% |
Dec 31, 2024 | 232.70M | -8.78% |
Dec 29, 2023 | 255.10M | -14.17% |
Dec 30, 2022 | 297.20M | -68.07% |
Dec 31, 2021 | 930.70M | -51.60% |
Dec 31, 2020 | 1.92B | -9.13% |
Dec 31, 2019 | 2.12B | 4.57% |
Dec 31, 2018 | 2.02B | 105.15% |
Dec 29, 2017 | 986.50M | 92.15% |
Dec 30, 2016 | 513.40M | -46.54% |
Dec 31, 2015 | 960.40M | 227.11% |
Dec 31, 2014 | 293.60M | 110.32% |
Dec 31, 2013 | 139.60M | -15.24% |
Dec 31, 2012 | 164.70M | 258.04% |
Dec 30, 2011 | 46.00M | 154.14% |
Dec 31, 2010 | 18.10M | -63.51% |
Dec 31, 2009 | 49.60M | 281.54% |
Dec 31, 2008 | 13.00M | -73.25% |
Dec 31, 2007 | 48.60M | 39.66% |
Dec 29, 2006 | 34.80M | -10.08% |
Dec 30, 2005 | 38.70M | -6.30% |
Dec 31, 2004 | 41.30M | -18.22% |
Dec 31, 2003 | 50.50M | 146.34% |
Dec 31, 2002 | 20.50M | -63.91% |
Dec 31, 2001 | 56.80M | 18.33% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 700.84B |
Johnson & Johnson | 375.37B |
AbbVie | 334.34B |
Novo Nordisk | 316.33B |
UnitedHealth Group | 279.90B |
Novartis AG | 242.35B |
Abbott Laboratories | 233.90B |
AstraZeneca | 218.65B |